Patents by Inventor Peter Byron Buckley

Peter Byron Buckley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9795630
    Abstract: A method of synergistically attenuating platelet hyperactivation and enhancing connective tissue regeneration including administering an aqueous parenteral solution to a subject, the aqueous parenteral solution containing a glycosaminoglycan having a weight average molecular weight from about 1.5 to about 6000 kD, and a concentration of about 0.1% to about 7.0%, a neutral colloidal polysaccharide having a weight average molecular weight of about 20 to about 75 kD, and a concentration of about 1.0% to about 25%, and an isomaltose oligomer having a weight average molecular weight of about 0.4 to about 8 kD, and a concentration of about 0.3% to about 25%.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: October 24, 2017
    Assignee: Glenpharma AB
    Inventors: Peter Byron Buckley, Konrad Messmer, Mark William Phillips
  • Publication number: 20160045534
    Abstract: A method of synergistically attenuating platelet hyperactivation and enhancing connective tissue regeneration including administering an aqueous parenteral solution to a subject, the aqueous parenteral solution containing a glycosaminoglycan having a weight average molecular weight from about 1.5 to about 6000 kD, and a concentration of about 0.1% to about 7.0%, a neutral colloidal polysaccharide having a weight average molecular weight of about 20 to about 75 kD, and a concentration of about 1.0% to about 25%, and an isomaltose oligomer having a weight average molecular weight of about 0.4 to about 8 kD, and a concentration of about 0.3% to about 25%.
    Type: Application
    Filed: October 28, 2015
    Publication date: February 18, 2016
    Applicant: Glenpharma AB
    Inventors: Peter Byron Buckley, Konrad Messmer, Mark William Phillips
  • Patent number: 9180089
    Abstract: A composition capable of attenuating platelet hyperactivation and associated methods for administering the same to a subject, the composition comprising an aqueous solution containing from about 0.1% to about 7.0% by weight of a glycosaminoglycan and from about 1.0% to about 32% by weight of a neutral polysaccharide.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: November 10, 2015
    Assignee: GLenpharma AB
    Inventors: Peter Byron Buckley, Konrad Messmer, Mark William Phillips
  • Publication number: 20120177600
    Abstract: A composition capable of attenuating platelet hyperactivation and associated methods for administering the same to a subject, the composition comprising an aqueous solution containing from about 0.1% to about 7.0% by weight of a glycosaminoglycan and from about 1.0% to about 32% by weight of a neutral polysaccharide.
    Type: Application
    Filed: September 21, 2010
    Publication date: July 12, 2012
    Inventors: Peter Byron Buckley, Konrad Messmer, Mark William Phillips